
Meta-regression coefficients, by drug class, S2 - accute
======================================================================================
                      Outcome               Class    Slope    CI.lb    CI.ub   P-value
--------------------------------------------------------------------------------------
5               All-cause Mortality        GLP-1RA   -1.28    -8.03     5.46    0.71  
1            Cardiovascular Mortality      GLP-1RA   -2.34    -8.35     3.68    0.45  
2                      MACE                GLP-1RA   -5.42    -11.89    1.05     0.1  
6              Myocardial Infarction       GLP-1RA     -4     -10.44    2.44    0.22  
7                     Stroke               GLP-1RA    0.28    -4.91     5.47    0.92  
3        Hospitalization for Heart Failure GLP-1RA   -2.83    -7.63     1.97    0.25  
4             Composite Renal Outcome      GLP-1RA    0.93    -5.57     7.44    0.78  
12              All-cause Mortality         SGLT2i   -0.33    -0.88     0.22    0.24  
8            Cardiovascular Mortality       SGLT2i   -0.53    -1.12     0.05    0.07  
9                      MACE                 SGLT2i   -1.88    -3.87     0.11    0.06  
13             Myocardial Infarction        SGLT2i    0.15    -2.49     2.78    0.91  
14                    Stroke                SGLT2i    0.08    -2.75     2.91    0.96  
10       Hospitalization for Heart Failure  SGLT2i   -1.44    -1.84    -1.05      0   
11            Composite Renal Outcome       SGLT2i   -0.31    -0.97     0.36    0.37  
--------------------------------------------------------------------------------------
Absolute risk difference and baseline cardiovascular mortality rate. Sensitivity      
